Sara M Elgendy[Author] - Search Results

Year	Number of Results
2020	3
2021	2
2022	4
2024	1

1

Cancer immunotherapy resistance: The impact of microbiome-derived short-chain fatty acids and other emerging metabolites.

Hersi F, Elgendy SM, Al Shamma SA, Altell RT, Sadiek O, Omar HA. Hersi F, et al. Among authors: elgendy sm. Life Sci. 2022 Jul 1;300:120573. doi: 10.1016/j.lfs.2022.120573. Epub 2022 Apr 22. Life Sci. 2022. PMID: 35469916 Review.

2

Ferroptosis: An emerging approach for targeting cancer stem cells and drug resistance.

Elgendy SM, Alyammahi SK, Alhamad DW, Abdin SM, Omar HA. Elgendy SM, et al. Crit Rev Oncol Hematol. 2020 Nov;155:103095. doi: 10.1016/j.critrevonc.2020.103095. Epub 2020 Sep 5. Crit Rev Oncol Hematol. 2020. PMID: 32927333 Review.

3

Tackling the cytokine storm in COVID-19, challenges and hopes.

Abdin SM, Elgendy SM, Alyammahi SK, Alhamad DW, Omar HA. Abdin SM, et al. Among authors: elgendy sm. Life Sci. 2020 Sep 15;257:118054. doi: 10.1016/j.lfs.2020.118054. Epub 2020 Jul 11. Life Sci. 2020. PMID: 32663575 Free PMC article. Review.

4

The dynamic association between COVID-19 and chronic disorders: An updated insight into prevalence, mechanisms and therapeutic modalities.

Alyammahi SK, Abdin SM, Alhamad DW, Elgendy SM, Altell AT, Omar HA. Alyammahi SK, et al. Among authors: elgendy sm. Infect Genet Evol. 2021 Jan;87:104647. doi: 10.1016/j.meegid.2020.104647. Epub 2020 Nov 29. Infect Genet Evol. 2021. PMID: 33264669 Free PMC article. Review.

5

Tangeretin as an adjuvant and chemotherapeutic sensitizer against various types of cancers: a comparative overview.

Alhamad DW, Elgendy SM, Al-Tel TH, Omar HA. Alhamad DW, et al. Among authors: elgendy sm. J Pharm Pharmacol. 2021 Mar 27;73(5):601-610. doi: 10.1093/jpp/rgab013. J Pharm Pharmacol. 2021. PMID: 33772294

6

Multi-Omics Analysis Revealed a Significant Alteration of Critical Metabolic Pathways Due to Sorafenib-Resistance in Hep3B Cell Lines.

Abushawish KYI, Soliman SSM, Giddey AD, Al-Hroub HM, Mousa M, Alzoubi KH, El-Huneidi W, Abu-Gharbieh E, Omar HA, Elgendy SM, Bustanji Y, Soares NC, Semreen MH. Abushawish KYI, et al. Among authors: elgendy sm. Int J Mol Sci. 2022 Oct 9;23(19):11975. doi: 10.3390/ijms231911975. Int J Mol Sci. 2022. PMID: 36233276 Free PMC article.

7

Design, synthesis, and biological evaluation of a new series of pyrazole derivatives: Discovery of potent and selective JNK3 kinase inhibitors.

Abu Rabah RR, Sebastian A, Vunnam S, Sultan S, Tarazi H, Anbar HS, Shehata MK, Zaraei SO, Elgendy SM, Al Shamma SA, Omar HA, Al-Tel TH, El-Gamal MI. Abu Rabah RR, et al. Among authors: elgendy sm. Bioorg Med Chem. 2022 Sep 1;69:116894. doi: 10.1016/j.bmc.2022.116894. Epub 2022 Jun 20. Bioorg Med Chem. 2022. PMID: 35764033

8

Autophagy inhibition potentiates energy restriction-induced cell death in hepatocellular carcinoma cells.

Elgendy SM, Zaher DM, Sarg NH, Abu Jayab NN, Alhamad DW, Al-Tel TH, Omar HA. Elgendy SM, et al. IUBMB Life. 2024 Mar 18. doi: 10.1002/iub.2816. Online ahead of print. IUBMB Life. 2024. PMID: 38497226

9

The inhibition of autophagy by spautin boosts the anticancer activity of fingolimod in multidrug-resistant hepatocellular carcinoma.

Alhamad DW, Elgendy SM, Hersi F, El-Seedi HR, Omar HA. Alhamad DW, et al. Among authors: elgendy sm. Life Sci. 2022 Sep 1;304:120699. doi: 10.1016/j.lfs.2022.120699. Epub 2022 Jun 8. Life Sci. 2022. PMID: 35690108

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

9 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year